The global cardiac biomarker diagnostic test kits market is poised for significant growth, with an estimated market size of ...

Ambient Biosciences, a pioneering life science company, today announced the launch of its Early Access Program (EAP), seeking ...

The study, which is being conducted under an FDA-approved Investigational Device Exemption application, held by GRAIL, leverages GRAIL's targeted methylation platform to detect ctDNA. With GRAIL's ...

The data shows that the TSO500 ctDNA v2 assay maintains high sensitivity for detecting tumor mutations, even with significant ...

Takara Bio launches automated, research-use-only (RUO), high-throughput qPCR system that saves infectious disease research ...

Roche (RHHBY) announced that it has received CE Mark for its Ventana FOLR1 RxDx Assay. This is the first immunohistochemistry, or IHC, ...

Turning to NGS, we saw strong performance driven primarily by customers developing and selling assays for myriad applications from rare disease and cancer diagnostics to liquid biopsy and beyond.

Woodbois Ltd, down 25% at 0.22p, 12-month range 0.22p-0.98p. The timber company has raised approximately GBP1.3 million through a subscription for 476.2 million new ordinary shares at 0.21p each. Says ...

AMSBIO’s CancerSeq™ FFPE tissues provide pre-screened tumour samples validated for single nucleotide polymorphisms (SNPs), ...

AbbVie has announced the European Commission (EC) has granted marketing authorization for ELAHERE (mirvetuximab soravtansine) ...